Technology

SMART M-Cell is a centrifugal separation system for blood and bone marrow cells, intended for clinical use by healthcare professionals. This page describes the cell populations involved and the processing programs available on the device.

CD34+ cells are a specialised population of haematopoietic stem cells, found most abundantly in bone marrow and also present in peripheral blood and umbilical cord blood. They are characterised by expression of the CD34 surface protein, which is the primary marker used to identify and isolate them for clinical applications.

What distinguishes these cells is their multipotent nature — the capacity to differentiate into a broad spectrum of cell types. These include red blood cells, responsible for oxygen transport; white blood cells, which drive immune protection; platelets, which enable coagulation; endothelial cells, which maintain vascular integrity; and myeloid cells, which play a central role in immune defence.

This differentiation potential is why CD34+ cells are the subject of ongoing clinical research across a wide range of medical fields.

At the core of SMART M-CELL is a proprietary automatic isolation and extraction system, backed by patented scientific technology. Engineered for precision, it is designed to optimize both cell viability and recovery rate ensuring that only the highest-quality stem cells are made available for therapeutic applications.
Where conventional centrifuges fall short, SMART M-CELL excels. By automatically adjusting RPM and centrifugation angles, the system delivers a precisely concentrated yield of stem cells and other key cells required for tissue regeneration. This level of control is critical to preserving cell functionality throughout the separation process.
Operating as a fully automated, closed system, SMART M-CELL eliminates the variability of manual handling resulting in a safer, more consistent, and highly efficient cell separation workflow.

SMART M-Cell includes four pre-set programs. Each applies a different LED light wavelength during the cycle. The treating physician selects the program appropriate to the clinical procedure being performed.